Search

everythinglearnresearchcommunity

for

Search:↓

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Tea leaf extract tonic promotes hair growth better than controls but has stability issues.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Temporal triangular alopecia is a non-scarring hair loss seen in some Asian children.

Mesenchymal stem cells can help repair body tissues with low risk of rejection.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Tea, especially green tea, shows promise in cosmetics for skin and hair benefits but more research is needed for effective use.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

VYC-12L effectively improves skin smoothness, reduces fine lines, and boosts hydration.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Topical finasteride is an effective and safer treatment for male hair loss.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Setipiprant did not significantly improve hair growth in men with hair loss.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

IGF-1 can help regrow hair and may be a promising treatment for hair loss.

Topical finasteride effectively and safely increases hair growth in men with hair loss.

Low-dose dutasteride effectively and safely promotes hair growth in men.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.